Stereotaxis (STXS) Notes Payables (2020 - 2021)

Stereotaxis (STXS) reported Notes Payables of $1.9 million for Q1 2021, up 61.57% quarter-over-quarter from $1.2 million in Q4 2020.

Stereotaxis (STXS) Notes Payables (2020 - 2021) Analysis & Trends

Stereotaxis (STXS) has 2 years of Notes Payables data on file, last reported at $1.9 million in Q1 2021.

Notes Payables for Q1 2021 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $1.9 million (changed N/A YoY), and the FY2020 annual result was $1.2 million, changed N/A from the prior year.
Notes Payables rose to $1.9 million in Q1 2021 per STXS's latest filing, from $1.2 million in the prior quarter.
Over five years, Notes Payables peaked at $2.2 million in Q2 2020 and troughed at $457244.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Stereotaxis	180.48 Mn	165.86 Mn	3.79 Mn

Download Data